Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario L Marques-Piubelli

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Journal of Hematopathology|November 16, 2024
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factorsWilliam Patrick Morrow, Nicholas S Milligan, Robert S Ohgami, et al.
Journal of Cutaneous Pathology|October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapyRiyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Journal of Cutaneous Pathology|May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinomaMario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
The American Journal of Dermatopathology|May 8, 2024
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous MelanomaDebora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, et al.
Cells|March 13, 2024
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis FungoidesMario L Marques-Piubelli, Jesus Navarrete, Debora A Ledesma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II TrialCamilla O Hoff, Simon Heeke, Yoshitsugu Mitani, et al.
Histopathology|March 30, 2023
CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapyMario L Marques-Piubelli, Do Hwan Kim, L Jeffrey Medeiros, et al.
Annals of Diagnostic Pathology|February 5, 2022
Adrenal cysts of lymphatic origin: A clinical and pathological study of six cases and systematic literature reviewMario L Marques-Piubelli, Eloiza Wilma Poma Gonzales, Victor Lucas Gonçalves, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2023
Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic RelevanceJuliana Mota Siqueira, Yoshitsugu Mitani, Camilla Oliveira Hoff, et al.
Experimental Hematology & Oncology|March 21, 2023
PD-L1<sup>+</sup> macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphomaRaphael E Steiner, Edwin R Parra, Francisco Vega, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Hematopathology|November 16, 2024
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factorsWilliam Patrick Morrow, Nicholas S Milligan, Robert S Ohgami, et al.
Journal of Cutaneous Pathology|October 8, 2021
Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapyRiyad N H Seervai, Woo Cheal Cho, Emily Y Chu, et al.
Journal of Cutaneous Pathology|May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinomaMario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
The American Journal of Dermatopathology|May 8, 2024
Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous MelanomaDebora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, et al.
Cells|March 13, 2024
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis FungoidesMario L Marques-Piubelli, Jesus Navarrete, Debora A Ledesma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II TrialCamilla O Hoff, Simon Heeke, Yoshitsugu Mitani, et al.
Histopathology|March 30, 2023
CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapyMario L Marques-Piubelli, Do Hwan Kim, L Jeffrey Medeiros, et al.
Annals of Diagnostic Pathology|February 5, 2022
Adrenal cysts of lymphatic origin: A clinical and pathological study of six cases and systematic literature reviewMario L Marques-Piubelli, Eloiza Wilma Poma Gonzales, Victor Lucas Gonçalves, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2023
Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic RelevanceJuliana Mota Siqueira, Yoshitsugu Mitani, Camilla Oliveira Hoff, et al.
Experimental Hematology & Oncology|March 21, 2023
PD-L1<sup>+</sup> macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphomaRaphael E Steiner, Edwin R Parra, Francisco Vega, et al.
Pageof 6